Abstract:Reduced hepatic glycogenesis is one of the most important causes of metabolic abnormalities in non-alcoholic fatty liver disease. Octreotide, a somatostatin analogue, has been demonstrated to promote weight loss and improve metabolic disorders in mice with high fat diet (HFD)-induced obesity. However, whether octreotide affects hepatic glycogenesis is unknown. The aim of the present study was to verify the effects of octreotide on hepatic glycogenesis in rats with HFD-induced obesity. Male Sprague-Dawley rats were fed a standard diet or a HFD for 24 weeks. Obese rats from the HFD group were further divided into a HFD-control group and an octreotide-administered group. Rats in the latter group were injected with octreotide for 8 days. Glucose and insulin tolerance tests were performed, and the area under the curve (AUC) was calculated. Following sacrifice, their body weights and lengths, fasting plasma glucose (FPG), fasting insulin (FINS), serum triglyceride (TG), total cholesterol (TC), free fatty acid (FFA), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured. In addition, Lee's index and the homeostatic model assessment index were calculated. Hepatic TG, FFA levels and glycogen content were first determined. Hepatic steatosis in the obese rats was assessed based on hematoxylin and eosin and Oil Red O staining. Human hepatoblastoma HepG2 cells were divided into a control group, a palmitate (PA)-treated group and a PA + octreotide-treated group. Establishment of the in vitro fatty liver model using HepG2 cells was confirmed by Oil Red O staining. The expression of phosphorylated Akt and glycogen synthase kinase 3 beta (GSK3 beta) was detected by western blotting, and glycogen synthase (GS) mRNA levels were detected by reverse transcription-quantitative polymerase chain reaction. Compared with the control group, the body weight, Lee's index, AUC of the intraperitoneal glucose tolerance test and intraperitoneal insulin tolerance test, levels of FPG, FINS, TG, TC, FFA, ALT and AST, and HOMA index values were significantly increased in the obese rats. The body weight, levels of FPG and FINS, and the HOMA index were significantly reduced following octreotide treatment, whereas the decrease in Lee's index, the blood levels of ALT, AST, TC, TG and FFA, and the AUC did not reach statistical significance. Hepatic TG and FFA levels were significantly increased and hepatic glycogen content was significantly decreased in rats with HFD-induced obesity when compared with those in the control group. Octreotide intervention restored these alterations. The expression levels of phosphorylated Akt and GSK3 beta protein expression, as well as GS mRNA levels in the HFD group were lower when compared with those in the control group, whereas octreotide treatment reversed these reductions. The in vitro experiments demonstrated that the reduced levels of phosphorylated Akt and GSK3 beta protein, and GS mRNA in the PA-treated group were significantly reversed by octreotide treatment. In conclusion, the results indicate that octreotide improved hepatic glycogenesis and decreased FPG concentration in rats with HFD-induced obesity. These mechanisms may be associated with increased GS activity via the promotion of GSK3 beta phosphorylation. Therefore, octreotide may be regarded as a novel therapeutic strategy for HFD-induced obesity and obesity-associated metabolic disorders.

Effects of orphanin on gastric motility in diabetic gastroparesis rats

The Mechanism of Alpinia Officinarum Hance on Improvement of Diabetic Gastroparesis on Type 2 Diabetes Rats Induced by Streptozotocin Combined with High-Fat Diet Based on Gut Microbiota and Metabolomics

Effect of oligofructose on resistance to postoperative high-fat diet-induced damage of metabolism in diabetic rats after sleeve gastrectomy

Effects of orphanin FQ on colonic motility of rats

[Association of gastric emptying with ghrelin, obestatin and receptor (GHSR, GPR-39) in hypothalamus of diabetic rats]

<i>Atractylodes</i><i> chinensis</i> volatile oil up-regulated IGF-1 to improve diabetic gastroparesis in rats

Supplementation of 17β-Estradiol Normalizes Rapid Gastric Emptying by Restoring Impaired Nrf2 and nNOS Function in Obesity-Induced Diabetic Ovariectomized Mice

Prokinetic Effects of Ghrelin in Streptozotocin-Induced Diabetic Guinea Pigs

Relationships Between Gastric Emptying and Plasma Ghrelin and Obestatin Levels in the Early Stages of Streptozotocin-Induced Diabetic Rats

Gastric Motor Effects of Ghrelin and Growth Hormone Releasing Peptide 6 in Diabetic Mice with Gastroparesis

Therapeutic Effects of Ghrelin and Growth Hormone Releasing Peptide 6 on Gastroparesis in Streptozotocin-Induced Diabetic Guinea Pigs in Vivo and in Vitro

Prokinetic Effects of A Ghrelin Receptor Agonist Ghrp-6 in Diabetic Mice

Relationship between ghrelin and gastric emptying in diabetic rats at different stages

Ghrelin Improves Delayed Gastrointestinal Transit in Alloxan-Induced Diabetic Mice.

Study on the influence of acupoints selection on ghrelin and GHSR expression in gastric fundus tissue of DGP rats

Role of Oxidative Stress in Gastric Motility of Diabetic Rats

The role of Ghrelin and its receptor agonists in diabetic gastroparesis

Increased Expression of Hypoxia Inducible Factor-1 Alpha and Vascular Endothelial Growth Factor is Associated with Diabetic Gastroparesis

Effect of Electroacupuncture on Platelet-derived Growth Factor and the Ultrastructure of Mitochondria in Rats with Diabetic Gastroparesis

Effects of Octreotide on Hepatic Glycogenesis in Rats with High Fat Diet-Induced Obesity

[Dual regulation of Qizhiweitong particles on gastric motility in the model rats with gastroparesis]